INTRODUCTION
Chronic renal failure is often associated with infertility/sterility. The first successful pregnancy in women with transplanted kidney is described in 1963. Pregnancy in a woman with a transplanted kidney due to the great progress of surgical techniques and immunosuppressive drugs, can be successful today, even though there is a possibility of complications both for the mother and the fetus (1).
CASe RepORT
The patient was born in 1979. Since the age of 14 has suffered from hypertension. At the age of 27, due to the atrophy of kidney, she underwent the transplantation of her father's kidney. Three years later, she spontaneously conceived and miscarried in the first trimester of pregnancy. Spontaneously conceived again after one year. The course of pregnancy was normal with regular ambulatory control at the nephrologist and gynecologist. In the 35 th week, she was admitted to our hospital for treatment and supervision. For immunosuppression she was taking tacrolimus 3,0,2.5 mg and azathioprine 50 mg 3x1 tbl. For the blood pressure control she was taking diltiazem 60 mg 2x1 tbl and bisoprolol-fumarate 1.25 mg 1 tbl. The blood pressure values were less than 140/90 mmHg. The laboratory values of urea, creatinine, protein in 24-hour urine collection and creatinine clearance were within normal values. The OGTT with 75 g of glucose: 0 minutes = 4.6 mmol/L, 120 minutes = 4.9 mmol/L. Urine cultures were sterile. Serological testing for TORCH was negative. The concentrations of tacrolimus in the blood were measured twice a week and the nephrologist corrected the dose twice (3, 0, 3 mg and 4, 0, 4 mg). The ultrasound examination of the fetus was normal, with normal fetal growth and development appropriate for the age. Spontaneous childbirth began with regular labours in the 40th week of pregnancy. Childbirth by C-section due to the fetal bradycardia. A female child was born, 2880 g/49 cm, apgar scora 8/9. The patient was released on the 7th postoperative day. Bromocriptine was introduced for the purpose of ablactation.
DISCUSSION
Terminal renal disease changes the function of the hypothalamus-pituitary-ovarian axis, which can affect the menstrual cycle (amenorrhea, oligomenorrhea, anovulation) and cause infertility. The increased concentration of prolactin, FSH and LH is common in patients with terminal renal disease. Disorder of the menstrual cycle (from oligomenorrhea to amenorrhea) was noticed in 74% of patients with termi-nal renal disease (2) . Shortly after the transplantation, the normal function of hormones and the menstrual cycle was re-established (2) . The rate of pregnancy in patients on dialysis is 1:200, and in patients with transplanted kidney 1:50 (3). A year after kidney transplantation is the optimal time for pregnancy, provided that in the past year there was no acute rejection in terms of transplant rejection and that the transplant's function is stable.
The stability of the transplant is shown by the creatinine values below 1.5 mg/dL, proteinuria greater than 500 mg in 24 hours. With minimal doses of immunosuppressive drugs (4) . The recommended maximum dose of prednisone was 15 mg/day, azathioprine 2 mg/ kg/day and therapeutic doses of cyclosporine or tacrolimus (1). Mycophenolate mofetil and sirinolimus are contraindicated in pregnancy and should be discontinued 6 weeks before the conception (1) .
In each pregnant woman with kidney transplantation, the acute reaction of transplant rejection can occur. If the function of the transplant was stable at the time of conception, the risk of transplant rejection is the same as in pregnant women and women who are not pregnant. Davison and co-workers reported that the values of serum creatinine> 1.5 mg/dL and proteinuria> 500 mg/24 hours significantly increase the risk of transplant rejection (4). The pregnancy does not have a negative impact on the transplant function (3) .
In pregnant women with a transplanted kidney in relation to the general population of pregnant women there is an increased incidence of hypertension (30% vs. 4-10%) and preeclampsia (15-25% vs. 6-8%). Chronic arterial hypertension in pregnancy (CAH) is a common problem in pregnant women with transplanted kidney. Blood pressure should be maintained at the values of patients that are not pregnant (<140/90 mmHg). The CAH is associated with an increased incidence of placental abruption, acute renal failure and mother's cardiac decompensation, as well as an increased incidence of intrauterine growth restriction (2). The increased incidence of gestational hypertension is associated with the use of immunosuppressive therapy, mainly with cyclosporine, tacrolimus and corticosteroids. Some studies describe an increased incidence of gestational diabetes, especially in pregnant women who were treated with corticosteroids and tacrolimus, while other studies deny a higher incidence of gestational diabetes in relation to other pregnancies (5, 6) .
Our pregnant woman has suffered from arterial hypertension since the age of 14. With antihypertensive therapy, the blood pressure values were below 140/90 mmHg. The proteins in the single urine of 24-hour urine collection were within the limits of reference values. She did not have gestational diabetes.
Numerous studies have shown that the incidence of premature births and births of children of low birth weight are higher in women with a transplanted kidney in relation to the general population of pregnant women and amounts 30-50% (3, 4) . Therefore, in these pregnant women more often ultrasound and clinical monitoring of fetal growth and development is needed. The incidence of fetal malformations was not increased in women with a transplanted kidney compared to the general population of pregnant women and amounts about 3% (5).
The C-section is not an indication for the completion of pregnancy in women with a transplanted kidney. The increased incidence of C-section is probably associated with an increased incidence of preeclampsia, preterm birth and intrauterine growth restriction (5). In our patient the childbirth started spontaneously in the 40th week of pregnancy, with regular labours, but because of fetal bradycardia it completed by the C-section.
Pregnant women with a transplanted kidney are at an increased risk for developing anemia and urinary tract infections. Urinary tract infections occur in 42% of women with a transplanted kidney, while the rare development of pyelonephritis (4) . Because of the immunosuppressive therapy those pregnant women are subject to opportunistic infections, cytomegalovirus, herpes simplex virus, toxoplasmosis, and hepatitis B and C.
The most commonly used immunosuppressive drugs as cyclosporine, tacrolimus, corticosteroids, azathioprine, mycophenolate-mofetil, mycophenolate sodium, sirolimus and everolimus. The side effects of immunosuppressive therapy in pregnant women are hypertension, impaired renal function and immunosuppression of the fetus. Many immunosuppressive drugs are teratogenic in animals. However, the occurrence of malformations in children whose mothers were taking immunosuppressive drugs is not statistically significant compared to the general population. (7) . Due to the physiological changes in pregnancy the changes in the metabolism of the drug are possible as well, and therefore the concentration of drug in the blood of pregnant women should be regularly monitored and the dose values adjusted to the pregnancy (7).
Our pregnant woman was treated before pregnancy with tacrolimus and mycophenolate-mofetil which was preconceptionally replaced with azathioprine. According to the FDA's (Food and Drug Administration)classification of pregnancy risk categories, tacrolimus falls into the category C, while azathioprine and mycophenolate-mofetil into the category D. Mycophenolate-mofetil (MMF) is contraindicated in pregnancy because its administration is associated with an increased incidence of congenital anomalies of the fetus (2). Therefore 33% (25 of 77) of pregnant women taking MMF during the pregnancy suffered a spontaneous miscarriage and 18% (14 of 77) of children were born with malformations. The most common malformations are cleft lip and palate, micrognathia, hypertelorism, anomalies of the eyes, ears and lower extremities, heart, esophagus and kidney (5). Azathioprine can cause anemia, thrombocytopenia, immune deficiency in the fetus and increased susceptibility to infections. Recent studies indicate that the use of azathioprine in pregnancy is associated with an increased incidence of premature births and giving birth to children of low weight (5). The incidence of hypertension and preeclampsia in pregnant women who were taking tacrolimus is less compared to those taking cyclosporine (5).
CONCLUSION:
Pregnancy after kidney transplantation can be successful. Pregnancy does not have a negative impact on the function of the transplant if the pregnancy occurred when a stable transplant function was achieved. According to the current recommendations, pregnancy one year after the transplantation of the kidney is considered safe. Pregnant women with a transplanted kidney are at an increased risk for developing hypertension and preeclampsia and the increased incidence of preterm birth and intrauterine growth restriction. These are high-risk pregnancies that require enhanced monitoring and a multidisciplinary approach.
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